HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joonas H Kauppila Selected Research

Toll-Like Receptor 9

1/2016Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.
9/2015Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
6/2015Tumor infiltrating CD8+ T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.
8/2014Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.
4/2012Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.
10/2011Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
1/2011Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joonas H Kauppila Research Topics

Disease

34Neoplasms (Cancer)
12/2022 - 01/2011
14Adenocarcinoma
07/2022 - 10/2011
13Esophageal Neoplasms (Esophageal Cancer)
12/2022 - 01/2014
6Barrett Esophagus (Barrett's Esophagus)
11/2018 - 04/2016
6Carcinoma (Carcinomatosis)
09/2017 - 01/2011
5Hypoxia (Hypoxemia)
11/2018 - 09/2012
5Breast Neoplasms (Breast Cancer)
01/2016 - 04/2012
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 06/2013
4Squamous Cell Carcinoma of Head and Neck
09/2017 - 01/2013
4Tongue Neoplasms (Tongue Neoplasm)
02/2017 - 01/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2022 - 01/2011
3Obesity
01/2022 - 01/2019
3Neoplasm Metastasis (Metastasis)
10/2020 - 03/2014
3Margins of Excision
11/2018 - 12/2017
2Myoma
09/2015 - 08/2014
1Metaplasia
09/2022
1Mental Disorders (Mental Disorder)
01/2022
1Dyspnea (Shortness of Breath)
01/2020
1Weight Loss (Weight Reduction)
08/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Esophageal Squamous Cell Carcinoma
01/2019
1Pain (Aches)
05/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2017
1Stroke (Strokes)
01/2017
1Pathologic Dilatation (Ectasia)
03/2014
1Triple Negative Breast Neoplasms
12/2013
1Inflammation (Inflammations)
12/2013
1Colorectal Neoplasms (Colorectal Cancer)
06/2013
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2013
1Carcinogenesis
04/2013
1Lymphatic Metastasis
01/2013

Drug/Important Bio-Agent (IBA)

7Toll-Like Receptor 9IBA
01/2016 - 01/2011
6Toll-Like Receptors (Toll-Like Receptor)IBA
11/2018 - 01/2014
6DNA receptor (receptor, DNA)IBA
01/2016 - 10/2011
5LigandsIBA
04/2016 - 09/2012
4Small Interfering RNA (siRNA)IBA
07/2014 - 09/2012
3Toll-Like Receptor 5IBA
09/2022 - 04/2013
3Fibronectins (Fibronectin)IBA
01/2019 - 02/2017
3TenascinIBA
01/2019 - 02/2017
3Biological ProductsIBA
07/2018 - 12/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 06/2013
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
04/2021 - 04/2017
2Hematoxylin (Haematoxylon)IBA
12/2020 - 01/2019
2Eosine Yellowish-(YS) (Eosin)IBA
12/2020 - 01/2019
2cyclo(Arg-Pro) (CI 4)IBA
01/2020 - 05/2018
2ORALIT (ORS)IBA
11/2018 - 12/2017
2N 30IBA
09/2017 - 04/2016
2Matrix Metalloproteinases (MMPs)IBA
07/2014 - 06/2013
2Tissue Inhibitor of Metalloproteinase-3IBA
07/2014 - 09/2012
1Hemoglobins (Hemoglobin)IBA
03/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1CI 22IBA
01/2020
1Carbonic Anhydrase IXIBA
11/2018
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
11/2018
1Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
09/2017
1Vascular Endothelial Growth Factor CIBA
09/2017
1Lactic Acid (Lactate)FDA LinkGeneric
04/2017
1Coloring Agents (Dyes)IBA
02/2017
1AntibodiesIBA
02/2017
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017
1SecurinIBA
11/2016
1Nucleic AcidsIBA
05/2016
1Peptides (Polypeptides)IBA
01/2016
1CathelicidinsIBA
01/2016
1matrigelIBA
08/2014
1Capsules (Microcapsules)IBA
03/2014
1Chloroquine (Aralen)FDA LinkGeneric
12/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2013
1CathepsinsIBA
12/2013
1Bacterial DNAIBA
06/2013
1Collagen Type I (Type I Collagen)IBA
01/2013
1CytokinesIBA
01/2013
1ChemokinesIBA
01/2013
1Chemokine CCL5IBA
01/2013
1CollagenIBA
01/2013
1Cathepsin KIBA
01/2013
1Cysteine Proteases (Cysteine Protease)IBA
01/2013
1A-Form DNA (A-DNA)IBA
09/2012
1Gonadal Steroid Hormones (Sex Hormones)IBA
04/2012
1Estrogen ReceptorsIBA
04/2012
1bicalutamide (Casodex)FDA LinkGeneric
04/2012
1Messenger RNA (mRNA)IBA
04/2012
1Protein Isoforms (Isoforms)IBA
04/2012
1Proteins (Proteins, Gene)FDA Link
01/2011
1Biomarkers (Surrogate Marker)IBA
01/2011

Therapy/Procedure

12Esophagectomy
12/2022 - 12/2016
11Neoadjuvant Therapy
04/2022 - 01/2016
6Therapeutics
12/2022 - 04/2012
5Lymph Node Excision (Lymph Node Dissection)
07/2022 - 12/2016
5Gastrectomy
01/2022 - 12/2016
4Drug Therapy (Chemotherapy)
01/2022 - 12/2013
2Minimally Invasive Surgical Procedures
03/2022 - 01/2022
2Bariatric Surgery
01/2022 - 01/2019
2Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2022 - 01/2022
1Palliative Care (Palliative Therapy)
10/2020
1Stents
12/2019
1Length of Stay
01/2018
1Neck Dissection (Radical Neck Dissection)
03/2014